K Pharma,Inc. Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,708	2,791	2,268	3,266	1,336	188
Cash & Short-Term Investments	2,708	2,791	2,268	3,266	1,336	188
Cash Growth	30.00%	23.06%	-30.56%	144.46%	610.64%	-
Inventory	11	11	5	10	10	9
Prepaid Expenses	17	57	39	31	22	6
Other Current Assets	41	31	36	1	2	1
Total Current Assets	2,777	2,890	2,348	3,308	1,370	204
Long-Term Investments	44	48	4	4	3	1
Other Long-Term Assets	-	1	1	1	1	-
Total Assets	2,821	2,939	2,353	3,313	1,374	205
Accounts Payable	8	8	10	11	10	2
Accrued Expenses	64	69	48	30	21	17
Current Income Taxes Payable	4	19	1	76	1	-
Other Current Liabilities	7	5	4	61	1	4
Total Current Liabilities	133	101	63	178	33	23
Long-Term Debt	1,599	1,500	-	-	-	-
Other Long-Term Liabilities	74	73	32	31	5	4
Total Liabilities	1,806	1,674	95	209	38	27
Common Stock	10	10	100	854	100	100
Additional Paid-In Capital	2,248	2,248	3,004	3,003	2,249	699
Retained Earnings	-1,243	-993	-846	-752	-1,012	-620
Comprehensive Income & Other	-	-	-	-1	-1	-1
Shareholders' Equity	1,015	1,265	2,258	3,104	1,336	178
Total Liabilities & Equity	2,821	2,939	2,353	3,313	1,374	205
Total Debt	1,649	1,500	-	-	-	-
Net Cash (Debt)	1,059	1,291	2,268	3,266	1,336	188
Net Cash Growth	-49.16%	-43.08%	-30.56%	144.46%	610.64%	-
Net Cash Per Share	91.22	111.25	195.44	289.79	143.18	24.73
Filing Date Shares Outstanding	11.62	11.61	11.6	11.32	9.33	7.6
Total Common Shares Outstanding	11.62	11.61	11.6	11.32	9.33	7.6
Working Capital	2,644	2,789	2,285	3,130	1,337	181
Book Value Per Share	87.35	109.00	194.58	274.20	143.18	23.42
Tangible Book Value	1,015	1,265	2,258	3,104	1,336	178
Tangible Book Value Per Share	87.35	109.00	194.58	274.20	143.18	23.42